Sarborg Limited Closes $10 Million Seed Round to Expand Proprietary Agentic Approach
Funding supports next-generation AI agent development and proprietary Intellectual Property, focused initially on pharmaceutical drug-repurposing Initial clients reporting commercial success, revolutionizing indication selection of lead programs Early commercial success and key partnerships signal strong market traction and scalability potential into multiple commercial verticals WILMINGTON, Del., Aug. 27, 2025 (GLOBE NEWSWIRE) — Sarborg Limited (“Sarborg” or […]
Continue Reading